Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

13
Number of overlapping holdings
54.2%
% of PJP's 24 holdings also in XPH
35.1%
% of XPH's 40 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 6.0% | 5.6% | 5.6% | |
MERCK & CO. INC. | 5.8% | 4.2% | 4.2% | |
JOHNSON & JOHNSON | 5.6% | 4.0% | 4.0% | |
PFIZER INC | 5.4% | 3.8% | 3.8% | |
JAZZ PHARMACEUTICALS PLC | 3.3% | 4.5% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
ABBVIE INC | 6.0% | |
AMGEN INC | 5.9% | |
GILEAD SCIENCES INC | 5.8% | |
ABBOTT LABORATORIES | 5.6% | |
TRAVERE THERAPEUTICS, INC. | 3.7% | |
VALEANT PHARMACEUTICALS INT'L | 3.6% | |
TARO PHARMACEUTICAL INDUS | 3.6% | |
REGENERON PHARMACEUTICALS | 3.4% | |
GERON CORP | 3.4% | |
BIOGEN IDEC INC | 3.4% |
PJP Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% | |
ELANCO ANIMAL HEALTH, INC. | -5.7% | |
CATALENT INC | -5.5% | |
ZOETIS INC | -4.8% | |
VIATRIS, INC. | -4.5% | |
AXSOME THERAPEUTICS, INC. | -4.4% | |
BRISTOL-MYERS SQUIBB CO | -3.9% | |
ORGANON & CO. | -3.8% | |
ROYALTY PHARMA PLC CLASS A | -3.7% | |
INTRA-CELLULAR THERAPIES INC | -3.6% |